Back to Search
RALPH RAFFA, M.D.
M.D.
Diagnostic Radiology Physician
NPI: 1952345720Individual
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
ME37459(FL)
Research & Publications (20)
The chemokine system and CCR5 antagonists: potential in HIV treatment and other novel therapies.
PMID 19250135·J Clin Pharm Ther·2009
6-review
Topiramate antagonizes NMDA- and AMPA-induced seizure-like activity in planarians.
PMID 19447129·Pharmacol Biochem Behav·2009
7-preclinical
Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine.
PMID 19422392·Br J Pharmacol·2009
4-observational
Considerations on the use of oxymorphone in geriatric patients.
PMID 19614559·Expert Opin Drug Saf·2009
6-review
The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians.
PMID 18342307·Eur J Pharmacol·2008
7-preclinical
Withdrawal-like behavior in planarians is dependent on drug exposure duration.
PMID 18511196·Neurosci Lett·2008
7-preclinical
Looking beyond the administered drug: metabolites of opioid analgesics.
PMID 18655760·J Fam Pract·2008
6-review
Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory.
PMID 18463849·Psychopharmacology (Berl)·2008
7-preclinical
Agmatine: identification and inhibition of methamphetamine, kappa opioid, and cannabinoid withdrawal in planarians.
PMID 18792993·Synapse·2008
4-observational
Role of pharmacogenetics in variable response to drugs: focus on opioids.
PMID 18370860·Expert Opin Drug Metab Toxicol·2008
6-review
Behavioral characterization of serotonergic activation in the flatworm Planaria.
PMID 18469535·Behav Pharmacol·2008
7-preclinical
Basic pharmacology relevant to drug abuse assessment: tramadol as example.
PMID 18315774·J Clin Pharm Ther·2008
6-review
Unexceptional seizure potential of tramadol or its enantiomers or metabolites in mice.
PMID 18292293·J Pharmacol Exp Ther·2008
4-observational
The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'.
PMID 18178175·Brain Res·2008
7-preclinical
Nociceptin attenuates methamphetamine abstinence-induced withdrawal-like behavior in planarians.
PMID 18479746·Neuropeptides·2008
7-preclinical
Nonlinear isobologram and superadditive withdrawal from cocaine: cannabinoid combinations in planarians.
PMID 17141755·Eur J Pharmacol·2007
7-preclinical
An NMDA antagonist (LY 235959) attenuates abstinence-induced withdrawal of planarians following acute exposure to a cannabinoid agonist (WIN 55212-2).
PMID 17306870·Pharmacol Biochem Behav·2007
7-preclinical
Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists.
PMID 17368613·Eur J Pharmacol·2007
7-preclinical
The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use.
PMID 17489873·J Clin Pharm Ther·2007
6-review
Differential behavioral effect of the TRPM8/TRPA1 channel agonist icilin (AG-3-5).
PMID 17765220·Eur J Pharmacol·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1825 SE TIFFANY AVE, SUITE 104
PORT ST LUCIE, FL 34952 - Phone
- (772) 398-2233
Quick Facts
- NPI
- 1952345720
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile